Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Clinical trial NCT02338037 · COMPLETED

Trial details

NCT number: NCT02338037
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Adult Brain Primary Brain Tumor

Start date: 2015-05-19
Primary completion: 2017-08-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.